These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7993593)

  • 1. The prognostic significance of c-erbB-2 and p53 protein expressions in gastric carcinoma--a multivariate analysis of prognostic factors.
    Kim JP; Oh ST; Hwang TS; Chi JG
    J Korean Med Sci; 1994 Jun; 9(3):248-53. PubMed ID: 7993593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of p53 protein, c-erbB-2 protein, epidermal growth factor receptor protein and proliferating cell nuclear antigen in gastric carcinoma.
    Jang WI; Yang WI; Lee CI; Kim HS; Song KS; Cho MY; Park JK; Shim YH
    J Korean Med Sci; 1993 Aug; 8(4):293-304. PubMed ID: 7911025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
    Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
    Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer.
    Rudland PS; Platt-Higgins A; Renshaw C; West CR; Winstanley JH; Robertson L; Barraclough R
    Cancer Res; 2000 Mar; 60(6):1595-603. PubMed ID: 10749128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
    Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
    Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p53 protein in gastric carcinomas is not independently prognostic.
    Motojima K; Furui J; Kohara N; Ito T; Kanematsu T
    Surgery; 1994 Nov; 116(5):890-5. PubMed ID: 7940194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.
    Lee KE; Lee HJ; Kim YH; Yu HJ; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
    Jpn J Clin Oncol; 2003 Apr; 33(4):173-9. PubMed ID: 12810831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
    Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
    J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of c-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma.
    Yonemura Y; Ninomiya I; Ohoyama S; Kimura H; Yamaguchi A; Fushida S; Kosaka T; Miwa K; Miyazaki I; Endou Y
    Cancer; 1991 Jun; 67(11):2914-8. PubMed ID: 1673870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas.
    van der Zee AG; Hollema H; Suurmeijer AJ; Krans M; Sluiter WJ; Willemse PH; Aalders JG; de Vries EG
    J Clin Oncol; 1995 Jan; 13(1):70-8. PubMed ID: 7799045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of apoptotic, Bcl-2, c-erbB-2 and p53 tumor markers in salivary gland malignancies.
    Nagler RM; Kerner H; Ben-Eliezer S; Minkov I; Ben-Itzhak O
    Oncology; 2003; 64(4):389-98. PubMed ID: 12759537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of p53 and c-erbB-2 in breast carcinoma: relation with epidemiologic factors, histologic features and prognosis.
    Fernández Aceñero MJ; Farina González J; Arangoncillo Ballesteros P
    Gen Diagn Pathol; 1997 Jun; 142(5-6):289-96. PubMed ID: 9228251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between HER-2, COX-2, p53 and clinicopathologic features in gastric adenocarcinoma. Do these biomarkers have any prognostic significance?
    Ugraş N; Özgün G; Ocakoğlu G; Yerci Ö; Öztürk E
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():176-81. PubMed ID: 25910300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical significance of p53 accumulation in gastric carcinoma.
    Starzynska T; Markiewski M; Domagala W; Marlicz K; Mietkiewski J; Roberts SA; Stern PL
    Cancer; 1996 May; 77(10):2005-12. PubMed ID: 8640663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-expression of p53 and c-erbB-2 oncoproteins in laryngeal carcinoma.
    Kazkayasi M; Hücümenoğlu S; Siriner GI; Hücümenoğlu M
    Eur Arch Otorhinolaryngol; 2001 Sep; 258(7):329-35. PubMed ID: 11699821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma.
    Micozkadioğlu D; Unal M; Pata YS; Baştürk M; Cinel L
    Med Sci Monit; 2008 Jun; 14(6):CR299-304. PubMed ID: 18509272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis, p53, and c-erbB-2 immunoreactivity and clinicopathological features in male breast cancer.
    Shpitz B; Bomstein Y; Sternberg A; Klein E; Liverant S; Groisman G; Bernheim J
    J Surg Oncol; 2000 Dec; 75(4):252-7. PubMed ID: 11135266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer.
    Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
    Anticancer Res; 1997; 17(4B):3091-7. PubMed ID: 9329609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival.
    Reinartz JJ; George E; Lindgren BR; Niehans GA
    Hum Pathol; 1994 Oct; 25(10):1075-83. PubMed ID: 7927313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.